*Result*: Guselkumab demonstrates long-term efficacy and maintenance of treatment response post-withdrawal in systemic-treatment naïve patients and non-responders to fumaric acid esters: Results from parts II and III of a randomised, active-comparator-controlled phase IIIb trial (POLARIS)
*Author/editor-in-chief*:
Thaҫi, Diamant (Verfasser); Pinter, Andreas (Verfasser) ; Sebastian, Michael (Verfasser); Termeer, Chritsian (Verfasser); Sticherling, Michael (Verfasser) ; Gerdes, Sascha (Verfasser) ; Schäkel, Knut (Verfasser) ; Wegner, Sven (Verfasser); Krampe, Stefanie (Verfasser) ; Bartz, Holger (Verfasser) ; Rausch, Christian (Verfasser); Taut, Friedemann (Verfasser) ; Eyerich, Kilian (Verfasser)
*Publication*:
Freiburg : Universität, 2024
*Physical description scale*:
1 Online-Ressource
*Format*:
*Language*:
*eng*
*Notes*:
British journal of dermatology. - 191, 1 (2024) , 36-48, ISSN: 1365-2133
*DOI*:
10.1093/bjd/ljad523